Neuroscience News

A drug that restores brain metabolism in mouse models of Alzheimer's also improved cognitive function, according to research from the Andreasson lab.

A team of neuroscientists at the Knight Initiative for Brain Resilience have zeroed in on a critical regulator of brain metabolism that may be over-activated in the brains of patients with Alzheimer’s disease.

Institute affiliates Brad Zuchero, Justin Du Bois and colleagues discovered that neurons require signaling from glia to become fully excitable, rather than by becoming excitable by default.

It may feel like you’re being more productive, but experts like Anthony Wagner say you’re not.

Time marches on predictably, but biological aging is anything but constant, according to new research by Michael Snyder and colleagues.

This week on From Our Neurons to Yours, we talk with Michelle Monje about her discovery that many cancers depend on nervous system innervation; she also discusses opportunities for novel therapies.

Groundbreaking research supported by the Knight Initiative for Brain Resilience at Stanford’s Wu Tsai Neurosciences Institute deepens our understanding of how the amino acid taurine may help reduce appetite and prevent obesity.

This week on From Our Neurons to Yours, we talk with Sergiu Pasca about using new techniques for growing human brain tissue in the lab to solve a rare neurological disorder.

Wu Tsai Neuro affiliate Lisa Giocomo has been named a Howard Hughes Medical Institute (HHMI) Investigator in the neurosciences, along with 10 other Stanford HHMI Investigators. This award highlights her exceptional research and dedication to mentoring the next generation of scientists.

This week, we talk with "radical behaviorist" Kim Bullock about how virtual reality technologies could serve as behavioral therapeutics to enhance psychotherapy.

The Knight Initiative's Year-End Symposium and Research Showcase featured a wide range of promising new approaches to understanding brain aging, resilience, and neurodegeneration.

This week, we talk with Zhenan Bao about reverse engineering the remarkable properties of human skin to design new wearable devices for neuroscience.

The drug, Kisunla, made by Eli Lilly, is the latest in a new class of treatments that could modestly slow cognitive decline in initial stages of the disease, but which also carry safety risks according to Knight Initiative for Brain Resilience affiliate Mike Greicius and others.

At the 2024 Neuro-omics Symposium, early-stage research funded by Wu Tsai Neuro's Big Ideas in Neuroscience program revealed exciting progress at the intersection of genomics and AI.

New software developed by the NeuroPlant Big Ideas in Neuroscience initiative turns an ordinary flatbed scanner and collection of nematode worms into a DIY platform to sniff out both beneficial and harmful plant-based molecules.

Researchers are closer to having a more precise method for efficiently treating depression, a new study suggests.